Pi is developing inhibitors for a novel target in the ubiquitin proteasome system, a pathway utilized by cancer cells for their growth and survival.

biopharmaceuticals
Private
Visit Website

NA

Additional Portfolio Companies
Adicet Bio
ARTSaVIT
ArQule
BioBlast Pharma
Cathworks
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Hairstetics
Headsense
Horama
Keros Therapeutics
Kite Pharma
Leap Therapeutics
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Nutrinia
Ocon Medical
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
Tisbury Pharmaceuticals
UroGen
V-Wave
Zolex Therapeutics
August 27, 2015